US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist

0.733
+0.012+1.73%

Close Nov 29 13:00 ET

0.769
+0.036+4.96%

Post 17:01 ET

28.97MMarket Cap-1979P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-63.92%1.88M

-51.59%3.07M

-34.58%3.83M

-25.94%22.92M

-30.28%5.5M

-34.60%5.22M

-17.60%6.34M

-20.61%5.85M

9.14%30.95M

24.01%7.89M

Selling and administrative expenses

-35.25%1.16M

-40.51%1.06M

-22.89%1.28M

-5.14%7.43M

5.40%2.19M

-2.25%1.8M

-2.05%1.78M

-20.81%1.66M

68.84%7.83M

-12.06%2.08M

-General and administrative expense

-35.25%1.16M

-40.51%1.06M

-22.89%1.28M

-5.14%7.43M

5.40%2.19M

-2.25%1.8M

-2.05%1.78M

-20.81%1.66M

68.84%7.83M

-12.06%2.08M

Research and development costs

-84.23%540.64K

-59.64%1.84M

-39.20%2.55M

-32.99%15.49M

-43.04%3.31M

-44.27%3.43M

-22.42%4.56M

-20.54%4.19M

65.51%23.12M

47.14%5.81M

Other operating expenses

--180.94K

--169.41K

----

Operating profit

63.92%-1.88M

51.59%-3.07M

34.58%-3.83M

25.94%-22.92M

30.28%-5.5M

34.60%-5.22M

17.60%-6.34M

20.61%-5.85M

-9.14%-30.95M

-24.01%-7.89M

Net non-operating interest income expense

-27.28%78.02K

-73.80%38.36K

-90.11%16.62K

82.87%463.26K

-69.20%41.53K

15.41%107.29K

454.99%146.39K

19,917.81%168.06K

110.42%253.32K

8,815.90%134.84K

Non-operating interest income

-27.28%78.02K

-73.80%38.36K

-90.11%16.62K

82.87%463.26K

-69.20%41.53K

15.41%107.29K

--146.39K

--168.06K

--253.32K

--134.84K

Other net income (expense)

330.92K

-100.00%-10

99.88%-18

-100.00%8

368.41%2.7M

-102.57%-15.37K

Other non- operating income (expenses)

----

--330.92K

----

-100.00%-10

99.88%-18

-100.00%8

----

1,118.79%2.7M

-102.57%-15.37K

Income before tax

64.69%-1.81M

56.40%-2.7M

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

Income tax

Net income

64.69%-1.81M

56.40%-2.7M

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

Net income continuous Operations

64.69%-1.81M

56.40%-2.7M

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

Minority interest income

Net income attributable to the parent company

64.69%-1.81M

56.40%-2.7M

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

64.69%-1.81M

56.40%-2.7M

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

Basic earnings per share

66.67%-0.05

61.11%-0.07

35.29%-0.11

21.69%-0.65

34.78%-0.15

21.05%-0.15

0.00%-0.18

26.09%-0.17

28.45%-0.83

-33.57%-0.23

Diluted earnings per share

66.67%-0.05

61.11%-0.07

35.29%-0.11

21.69%-0.65

34.78%-0.15

21.05%-0.15

0.00%-0.18

26.09%-0.17

28.45%-0.83

-33.57%-0.23

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-63.92%1.88M	-51.59%3.07M	-34.58%3.83M	-25.94%22.92M	-30.28%5.5M	-34.60%5.22M	-17.60%6.34M	-20.61%5.85M	9.14%30.95M	24.01%7.89M
Selling and administrative expenses	-35.25%1.16M	-40.51%1.06M	-22.89%1.28M	-5.14%7.43M	5.40%2.19M	-2.25%1.8M	-2.05%1.78M	-20.81%1.66M	68.84%7.83M	-12.06%2.08M
-General and administrative expense	-35.25%1.16M	-40.51%1.06M	-22.89%1.28M	-5.14%7.43M	5.40%2.19M	-2.25%1.8M	-2.05%1.78M	-20.81%1.66M	68.84%7.83M	-12.06%2.08M
Research and development costs	-84.23%540.64K	-59.64%1.84M	-39.20%2.55M	-32.99%15.49M	-43.04%3.31M	-44.27%3.43M	-22.42%4.56M	-20.54%4.19M	65.51%23.12M	47.14%5.81M
Other operating expenses	--180.94K	--169.41K	----	----	----	----	----	----	----	----
Operating profit	63.92%-1.88M	51.59%-3.07M	34.58%-3.83M	25.94%-22.92M	30.28%-5.5M	34.60%-5.22M	17.60%-6.34M	20.61%-5.85M	-9.14%-30.95M	-24.01%-7.89M
Net non-operating interest income expense	-27.28%78.02K	-73.80%38.36K	-90.11%16.62K	82.87%463.26K	-69.20%41.53K	15.41%107.29K	454.99%146.39K	19,917.81%168.06K	110.42%253.32K	8,815.90%134.84K
Non-operating interest income	-27.28%78.02K	-73.80%38.36K	-90.11%16.62K	82.87%463.26K	-69.20%41.53K	15.41%107.29K	--146.39K	--168.06K	--253.32K	--134.84K
Other net income (expense)		330.92K		-100.00%-10	99.88%-18	-100.00%8			368.41%2.7M	-102.57%-15.37K
Other non- operating income (expenses)	----	--330.92K	----	-100.00%-10	99.88%-18	-100.00%8	----	----	1,118.79%2.7M	-102.57%-15.37K
Income before tax	64.69%-1.81M	56.40%-2.7M	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M
Income tax
Net income	64.69%-1.81M	56.40%-2.7M	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M
Net income continuous Operations	64.69%-1.81M	56.40%-2.7M	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M
Minority interest income
Net income attributable to the parent company	64.69%-1.81M	56.40%-2.7M	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	64.69%-1.81M	56.40%-2.7M	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M
Basic earnings per share	66.67%-0.05	61.11%-0.07	35.29%-0.11	21.69%-0.65	34.78%-0.15	21.05%-0.15	0.00%-0.18	26.09%-0.17	28.45%-0.83	-33.57%-0.23
Diluted earnings per share	66.67%-0.05	61.11%-0.07	35.29%-0.11	21.69%-0.65	34.78%-0.15	21.05%-0.15	0.00%-0.18	26.09%-0.17	28.45%-0.83	-33.57%-0.23
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data